omiganan (CLS001) / Maruho 
Welcome,         Profile    Billing    Logout  

1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
omiganan (CLS001) / Maruho
2017-003106-41: Omiganan BID in patients with facial seborrheic dermatitis

Ongoing
2
36
Europe
Omiganan Topical Gel, Nizoral 20 mg/g, crème, CLS001, Nizoral 20 mg/g, crème, Gel, Cream, Nizoral 20 mg/g, crème
Cutanea Life Sciences, Cutanea Life Sciences
Mild to moderate facial seborrheic dermatitis., facial seborrheic dermatitis, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 

Download Options